Table 5.
Detailed menopause symptoms by the age and type of hormonal therapy (n=110)
| Variables | Age (year, mean±SD) | F/t (P) Scheffé | Hormonal therapy (mean±SD) | F/t (P) Scheffé | ||||
|---|---|---|---|---|---|---|---|---|
| <50 | 50-59 | >60 | Tamoxifen (n=43) | Aromatase inhibitor (n=52) | Tamoxifen + zoladex (n=13) | |||
| Sweating/flush | 2.69±1.04a | 1.65±1.10b | 1.19±1.27c | 13.30 (0.00) a>b, c | 2.12±1.07a | 1.44±1.30b | 2.54±1.20c | 6.40 (0.002) a, c>a, b |
| Cardiac complaints | 1.31±1.11 | 1.06±0.96 | 1.19±1.10 | 0.60 (0.553) | 1.23±1.07 | 1.17±1.04 | 1.00±0.82 | 0.26 (0.775) |
| Sleeping disorders | 2.28±1.22 | 1.61±1.22 | 1.92±1.55 | 2.49 (0.088) | 1.88±1.20 | 1.77±1.42 | 2.15±1.14 | 0.44 (0.647) |
| Joint and muscle complaints | 1.59±1.32a | 1.94±1.30b | 2.50±1.36c | 3.33 (0.039) a, b<c | 1.58±1.30a | 2.44±1.29b | 1.69±1.25c | 5.71 (0.004) |
| Depressed | 1.86±1.33 | 1.28±1.05 | 1.85±1.32 | 3.17 (0.46) | 1.44±1.20 | 1.60±1.24 | 1.92±1.26 | 0.78 (0.459) |
| Irritable | 2.07±1.19a | 1.28±0.88b | 1.81±1.42c | 5.30 (.006) a, c>b, c | 1.63±1.05 | 1.50±1.20 | 2.08±1.32 | 1.30 (0.277) |
| Anxious | 1.93±1.39 | 1.35±0.99 | 1.65±1.41 | 2.22 (0.114) | 1.51±1.03 | 1.56±1.27 | 2.08±1.50 | 1.15 (0.320) |
| Exhausted | 2.38±0.98a | 1.80±0.90b | 2.15±1.12c | 3.61 (0.030) | 2.00±0.98 | 2.04±0.99 | 2.31±1.11 | 0.49 (0.615) |
| Sexual problems | 1.76±1.30 | 1.91±1.38 | 1.46±1.30 | 0.97 (0.380) | 1.77±1.20 | 1.85±1.41 | 1.46±1.51 | 0.43 (0.651) |
| Urinary complaints | 1.14±1.27 | 1.43±1.04 | 1.42±1.21 | 0.67 (0.514) | 1.53±1.16 | 1.35±1.10 | 0.77±1.17 | 2.28 (0.107) |
| Vaginal dryness | 1.59±1.32a | 1.94±1.30b | 2.50±1.36c | 3.33 (0.039) a, b<b, c | 1.70±1.34 | 1.62±1.44 | 1.54±1.66 | 0.08 (0.927) |
SD: Standard deviation